CHO Pharma, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 138,000 compared to TWD 297,000 a year ago. Operating loss was TWD 309.556 million compared to TWD 369.163 million a year ago. Net loss was TWD 296.839 million compared to TWD 358.372 million a year ago. Basic loss per share from continuing operations was TWD 1.62 compared to TWD 1.96 a year ago.